RICOVR Healthcare
PrivateLast Round
Series A
Sep 13, 2024
Total Funding Raised
$6.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RICOVR Healthcare is a biotechnology company that develops a saliva-based biosensor testing platform for rapid point-of-care diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RICOVR Healthcare Comparables
Compare RICOVR Healthcare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hound Diagnostics | 87% | |
| Premier Biotech | 78% | |
| Cannabix Technologies Inc | 77% |
RICOVR Healthcare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 13, 2024 | ||||
| Grant | Jul 24, 2024 | ||||
| Grant | Jan 20, 2023 | ||||
| Pre Seed | Apr 19, 2021 | ||||
| Grant | Sep 15, 2020 | ||||
Seed | Apr 29, 2020 |
RICOVR Healthcare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| Achari Ventures | Pre Seed |
| National Institute on Drug Abuse | Grant |
| GenHenn Capital | Series A |
| New Jersey Economic Development Authority | Series A |
| NIH RADx | Grant |
| Yaax Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Named among Business Insider’s Top 26 Startups.
- Jul 22, 2026
Honored with multiple awards from the NJEDA.
RICOVR Healthcare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RICOVR Healthcare's valuation, stock price, and market status.
Is RICOVR Healthcare a public or private company?
RICOVR Healthcare is a private company.
What is the current stock price of RICOVR Healthcare?
RICOVR Healthcare is a private company, so its shares have no public market price. Caplight tracks RICOVR Healthcare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RICOVR Healthcare worth (valuation)?
Valuation information for RICOVR Healthcare is not publicly available.
Can I buy RICOVR Healthcare stock?
RICOVR Healthcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RICOVR Healthcare's last funding round?
RICOVR Healthcare's most recent funding round was Series A on September 13, 2024.
Who are the main investors in RICOVR Healthcare?
Key investors in RICOVR Healthcare include Achari Ventures, National Institute on Drug Abuse, GenHenn Capital, Yaax Capital, HALLEY Venture Partners LP.
Will RICOVR Healthcare IPO soon?
No public IPO plans have been announced for RICOVR Healthcare.
How can I track RICOVR Healthcare secondary market activity?
Caplight tracks bids, offers, and trades in RICOVR Healthcare's shares on secondary markets.